Hyperlipidaemia does not impair vascular endothelial function in glycogen storage disease type 1a.
Patients with glycogen storage disease type 1 (GSD-1) often have marked hyperlipidaemia with abnormal lipoprotein profiles. This metabolic abnormality improves, but is not fully corrected, with dietary therapy and therefore these patients may be at high risk for the development of atherosclerosis. Endothelial dysfunction is an early event in atherogenesis and can be detected in children and young adults at high risk. We studied endothelial function, using a non-invasive ultrasonographic method, in the brachial arteries of 6 adult GSD-1a patients (aged 23-33 years) with mean cholesterol of 7.9 mmol/l (range 4.7 to 14.6) and mean triglycerides of 9.1 mmol/l (range 4.1 to 21.3), and 12 age- and sex-matched normolipidaemic controls. Flow-mediated (endothelium-dependent) dilation was similar in patients and controls (8.2% vs. 10.5%; P = 0.20). Although the patient numbers are small, these results are consistent with the surprising lack of clinically evident atherosclerosis in GSD-1. The reasons these patients appear less susceptible to the damaging arterial effects of hyperlipidaemia are unknown. These results may have implications for others with secondary hyperlipidaemias.
Medical Unit, Institute of Child Health, London, UK.
P J
PJ
Lee
D S
DS
Celermajer
J
J
Robinson
S N
SN
McCarthy
D J
DJ
Betteridge
J V
JV
Leonard
D000328:Adult; D001161:Arteriosclerosis / Q000503:physiopathology; D004730:Endothelium, Vascular / Q000503:physiopathology; D005260:Female; D005953:Glycogen Storage Disease Type I / Q000503:physiopathology*; D006801:Humans; D006949:Hyperlipidemias / Q000378:metabolism / Q000503:physiopathology*; D008297:Male; D005996:Nitroglycerin / Q000494:pharmacology
D005996:Nitroglycerin